Disease Management Articles & Analysis

Caitlin Cameron, CEO, OtoNexus Technologies participated in the Puget Sound Business Journal Straight Talk: Innovations in Healthcare. The series brings together experts from the Puget Sound area to discuss trends in the healthcare innovation industry. Caitlin noted improvement in care can be achieved with more focus on healthcare innovation on tools for primary care physicians. This would ...

By OtoNexus Medical Technologies Inc.

There are self-driving cars, 5G smartphones, and now planes that travel from New York to London in 3.5 hours. The world we live in and the technology we use are rapidly evolving. But, when it comes to drug delivery methods, the 160-year old technology behind the needle and syringe has yet to catch wind of any radical transformation. With cutting-edge technology from MIT, Portal Instruments aims ...

By Portal Instruments, Inc.

We’re excited to announce that Nymbl Science has been selected as a finalist in the GSMA’s 2020 Global Mobile (GLOMO) Awards, the premier global competition for mobile technology and solutions, for Best Mobile Innovation for Health and Biotech! Other finalists in this category include Samsung, Ericsson, and Vimplecom. The GLOMO Awards celebrate key innovations and achievements from ...

By Nymbl Science, Inc.

On the basis of clinical success and acknowledged leadership in the field of celiac disease, the organizers of the International Celiac Disease Symposium (ICDS) have invited Jack Syage PhD, CEO of ImmunogenX, to deliver a panel talk and join the Conference Faculty. ICDS is held internationally every other year and is considered the premier conference for celiac disease. This year it will be held ...

By ImmunogenX, Inc.

Endotronix Ireland Limited, a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced today an Enterprise Ireland Industry Partnership project in a collaboration with Tyndall National Institute, a leading European Deep Tech research center in integrated ICT (Information and Communications Technology) hardware and software. The 12-month ...

By Endotronix, Inc.

Optos plc, the leading medical retinal imaging company, part of Nikon Corporation, is pleased to announce the launch of Silverstone at the American Academy of Ophthalmology, San Francisco, CA. Silverstone is the first of its kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture optomap® ...

By Optos, Inc.

Holdings Limited (Tencent),based in Shenzhen,China,signed a strategic collaboration memorandum to develop a service ecosystem focused on rare disease patients in China. The combined effort will promote education of rare disease,focus social awareness on rare disease,and improve accessibility of medical information and services for rare disease by working together to provide innovative digital ...

By RareStone Group

NEW YORK, Jan. 11, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be virtually presenting at the 39th Annual J.P. Morgan Healthcare Conference. Mr. Salman will introduce ...

By miR Scientific, LLC

NEW YORK, June 3, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company dedicated to transforming global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be presenting at the Jefferies Virtual Healthcare Conference. Mr. Salman will discuss the planned commercial ...

By miR Scientific, LLC

Sirenas, LLC ("Sirenas"), a biotechnology company harnessing computational approaches to discover therapeutics derived from nature's chemistry, announced that it has received a new grant from the Bill & Melinda Gates Foundation to advance ATLANTIS™, the company's proprietary drug discovery technology. With today's announcement, Sirenas has now received two research grant awards from ...

By Sirenas

Kaiser Permanente has been named No. 1 on the 2011 DiversityInc Top 50 Companies for Diversity list, reaching the top spot after first debuting on the publication's list in 2006. "We're particularly proud of this award in recognition of Kaiser Permanente's longstanding effort of promoting diversity and inclusion," said Chairman and Chief Executive Officer George Halvorson. "As an organization, ...

By CSRwire - Corporate Social Responsibility Newswire

Based on the results obtained from the CeliacShieldTM trial (NCT03585478) by ImmunogenX, Inc. and conducted at the Mayo Clinic, the work has been selected as a Lecture Presentation at the 2022 Digestive Disease Week® (DDW) Conference, the foremost gastroenterological event in the world, being held at the San Diego Convention Center, San Diego, CA on May 21-24. The presentation entitled: ...

By ImmunogenX, Inc.

Angiodroid won the 10° edition of Gaetano Marzotto Company Prize PGMX2031 and the Special Przie Unicredit StarLab. Angiodroid wins the Company Prize as the best innovative company with the ability to generate significant positive effects in the social, territorial, cultural or environmental areas. Angiodroid doubles, also winning the special prize Unicredit Starlab, entering the ...

By Angiodroid Spa

The U.S. SBA announced 38 companies, seven organizations and 14 individuals as the winners of the prestigious Tibbetts Award for their accomplishments in creating cutting-edge technologies. The Tibbetts Awards, named after Roland Tibbetts, the founder of the SBIR Program, honors these awardees for the exceptional successes they achieved through SBA’s SBIR program. An individual award was ...

By ImmunogenX, Inc.

Aidar Health, formerly known as Multisensor Diagnostics, has developed a portable hand-held device that allows patients to measure and track vital signs in a matter of seconds. Roughly the size of an iPhone, MouthLab consists of a hand unit and a mouthpiece that fits between the teeth and lips. The mouthpiece uses special sensors to gather information from breathing patterns, saliva and blood ...

By Aidar Health

TOPIC: E-health Adoption and Outcomes To-Date at Alberta Health Services Plenary Session 8 Healthcare Management Forum: Process Improvement and Operational Excellence WHEN: Tuesday, April 5 2011 at 9:45 a.m WHERE: Toronto Priority Code: 3BL1 Featuring: William Trafford, Senior Vice-President, Corporate Merger and Information Technology, Alberta Health Services How is Alberta Health ...

By 3BL Media

ImmunogenX is pleased to report the successful completion of the CeliacShield trial (NCT03585478), focused on treating celiac disease (CeD) patients, will be published in the premier journal Gastroenterology and is entitled: Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients with Celiac Disease Exposed to a Gluten Challenge doi.org/10.1053/j.gastro.2022.07.071 This ...

By ImmunogenX, Inc.

ImmunogenX is happy to announce the successful completion of the CeliacShield trial (NCT03585478). This gluten-challenge trial measured several outcomes including histology, symptoms, serology, and gluten in urine. The trial also incorporated our CypCel diagnostic technology as a monitor of small intestinal villous health utilizing the drug biomarker simvastatin as measured in blood samples. ...

By ImmunogenX, Inc.

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced the opening of a United States subsidiary in the Denver metropolitan area. The new office will increase logistical and commercial support for PixCell's U.S. clients and will handle order fulfilment across the country, as well as provide additional clinical and technical support to customers. "Opening a ...

By PixCell Medical Technologies

In collaboration with the International Society for Pediatric and Adolescent Diabetes (ISPAD) Novo Nordisk has today launched a training manual specific to the diagnosis and treatment of diabetes care for children in developing countries. Unveiled on the opening day of the ISPAD Congress 'ISPAD 2010', which is currently taking place in Buenos Aires, this first edition of the manual is available ...

By CSRwire - Corporate Social Responsibility Newswire